In Oct 2009 human C1-inh concentrate given at a dose of 20 U/kg was found to be safe, well tolerated and efficacious in diminishing time to relief onset when giving during acute facial or abdominal HAE attacks [7]. Here, SERPING1 is linked to hereditary angioedema.